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ABSTRACT: We studied the immune response
of wild House Sparrows (Passer domesticus )
experimentally challenged with different doses
of inactivated Newcastle disease virus (NDV)
vaccine. We evaluated within-individual cell-
mediated and humoral responses in birds
kept in outdoor aviaries, over a 6-wk period.
Nonbreeding adult House Sparrows developed
a significant humoral response to NDV exper-
imental vaccination within 1 wk postchallenge,
as measured by hemagglutination inhibition
assay; values increased until week 4 and
persisted until week 6. Differences among
treatments appeared by week 1, with individ-
uals challenged with the highest dose (0.2 mL)
eliciting a higher humoral response than the
rest (n518). By week 4, all individuals vacci-
nated displayed an increased humoral re-
sponse, with individuals challenged with the
highest dose remaining significantly above
responses of individuals vaccinated with the
middle dose (0.1 mL, n514), but not the lowest
dose (0.05 mL, n515). The middle and lowest
dose responded similarly and significantly
different from controls (n523). Differences
persisted through week 6 postchallenge. Cell-
mediated responses were independent of the
experimental treatment. All individuals experi-
enced a rise in granulocyte concentration,
whereas lymphocyte and monocyte concentra-
tions decreased, most likely as a result of
captivity. Adult wild House Sparrows immuno-
challenged with inactivated NDV vaccine
developed a specific humoral response, high-
lighting the utility of this technique in immu-
nologic and evolutionary ecology studies in wild
birds.
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Because parasites and pathogens can
have a critical effect on individual fitness,
protection against disease is of major
importance. However, pathogen avoid-
ance and investment in immune function
often interact with other vital parameters,
and even nonpathogenic immune chal-
lenges can induce relevant physiologic
changes in the host (Norris and Evans,
2000). Most of our knowledge about the
function and dynamics of immune re-
sponses comes from laboratory studies in
controlled environments or from studies
on inbred individuals of a small number of
model species. In contrast, natural popu-
lations exhibit wide genetic and environ-
mental diversity, and epizootic diseases
often involve vectors and hosts of a variety
of species that interact in a complex way
(Pedersen and Babayan, 2011).
Adaptive immunity is the most efficient
line of defense in vertebrates, as it targets
specific antigens, relying on both humoral
and cell-mediated immunity to ensure a
faster response to subsequent challenges.
The humoral response is mediated by
lymphocytes T and B that recognize
specific antigens, and secrete antibodies
to target them for destruction. Likewise,
cell-mediated immunity relies on a variety
of immune cells that are responsible for
antigen recognition and memory, produc-
tion of antibodies, and the elimination of
the specific antigen, among other func-
tions. However, little is known about
variability in the early dynamics of those
responses and their long-term persistence,
which limits their suitability for evolution-
ary and ecologic studies in the wild.
Immunologic research on wild avian
systems has been mostly restricted to
nonpasserine species, and the use of
antigens such as sheep red blood cells
(SRBC) or keyhole limpet hemocyanin
(KLH), to which birds have never been
naturally exposed. However, the study of
adaptive responses to specific wild patho-
gens can yield relevant information on
epidemiologic and evolutionary issues
concerning host–pathogen dynamics (De-
mas et al., 2011).
Newcastle disease virus (NDV) is a
globally distributed avian paramyxovirus
that causes highly contagious disease and
represents a severe problem for the
poultry industry (Alexander, 2009). Few
studies have been performed on the
specific immune response to NDV, espe-
cially in wild populations and nonmodel
species (Seal et al., 2000). Vaccination is a
common technique widely applied to
prevent and alleviate disease and as an
immunologic tool to study eco-epidemiol-
ogy in wild animal populations (e.g.,
Staszewski and Boulinier, 2004). The
development of new in vivo immunologic
methods can improve our understanding
of host–pathogen dynamics in the wild,
potential pathogen reservoirs, and epizo-
otics that may be crucial for endangered
species’ survival, and the study of passive
immunity (e.g., Garnier et al., 2011).
We assessed the immune response of
wild House Sparrows (Passer domesticus )
to immunization with NDV inactivated
vaccine. In particular, we aimed to deter-
mine the dosage eliciting a significant
immune response and the temporal pat-
tern of cell-mediated and humoral re-
sponses in adult House Sparrows. House
Sparrows are commonly exposed to a
variety of pathogens in the wild and are
sometimes considered a source of epizo-
otic threats because of the species’ close
association with humans and livestock
(Leighton and Heckert, 2007).
We captured 81 adult House Sparrows
in December 2009 in the vicinity of
Can˜ada de los Pa´jaros bird reserve in
Puebla del Rı´o, Sevilla, Spain (37u149N,
6u079W). Birds were housed in outdoor
cages (33332 m) with ad libitum food
and water. On day 2, blood samples
(0.2 mL) were taken and individuals were
randomly assigned to five treatments: 1–3)
inoculated subcutaneously with different
doses of a commercial inactivated New-
castle disease virus vaccine HIPRAVIARH
BPL2 109.5 EID50/0.5 mL (0.2 mL,
0.1 mL, or 0.05 mL), 4) inoculated with
the same oil adjuvant (0.1 mL) as the
commercial vaccine, or 5) inoculated with
sterile phosphate buffered saline (0.1 mL).
Sampling was repeated at 1, 4, and 6 wk
after experimental treatment. In all sam-
pling occasions except in week 4, a blood
drop (0.01 mL) was kept in a heparinized
tube for determination of leukocyte profile
by flow cytometry (see below). Treatment
doses were established according to the
manufacturer’s recommendations and
dosages used in previous studies (Saino
et al., 2002).
We used hemagglutination inhibition
(HI) to assess NDV antibody levels in
sera. The HI test is a classic indirect
diagnostic assay that is widely used and
serves as a gold standard for detecting
NDV antibodies in birds (Alexander,
2009). The concentration of NDV anti-
bodies was determined by adding 4
hemagglutinin units of HIPRAVIARH-
CLON (E.Newcastle, clon CL/79) antigen
to test sera sequentially diluted from 1:2 to
1:640. VLDIA053 (HAR-NDL, NDV
strain La Sota) and VLDIA030 (SPF-
CH-Chicken negative) were used as pos-
itive and negative controls, respectively.
Eleven individuals with initial HI titers
exceeding 1:16 were removed from the
analyses, as presumably these had been
previously exposed to NDV in the wild.
Leukocyte profiles were determined fol-
lowing Uchiyama et al. (2005) to estimate
relative lymphocyte, granulocyte, and
monocyte counts with the use of a flow
cytometer (Guava Easy Cyte Plus, Guava
Technologies, Hayward, California, USA).
Variation in NDV antibody concentration
(expressed as the inverse of the dilution
factor) was analyzed as the dependent
variable in a generalized linear mixed
model with normally distributed error
and identity link. Comparisons among
factor levels were done with post hoc t-
tests on least-squares means (Fig. 1).
Because adjuvant and control treatments
did not differ in any of the sessions (data
not shown), data were merged into a single
control group to improve statistical power.
Treatment and session were included as
main effects, with cage as a random factor
and individual as repeated subject as
implemented in proc GLIMMIX SAS 9.2.
Additionally, the analyses were repeated
with the leukocyte counts as covariates in
the previous models, and later as depen-
dent variables with treatment and session
as main effects and cage as random factor.
Degrees of freedom for fixed effects were
estimated by means of the between–within
approximation (SAS Institute Inc., 2009).
Differences in sample sizes among treat-
ments and sessions are due to a few
individuals escaping, and insufficient sera
for some laboratory analyses.
Sex (F1,6150.06; P50.81), the interaction
between sex and treatment (F3,5850.72;
P50.54), body mass (F1,11950.04; P50.84),
tarsus (F1,6152.11; P50.15), and wing
length (F1,6151.00; P50.32) were initially
included as covariates and later removed
from the models, as there was no significant
effect on the dependent variable.
Concentration of NDV antibodies in
response to vaccination varied by treatment
(F3,62512.55; P,0.0001), and by experi-
mental session (F3,120523.55; P,0.0001;
Fig. 1). Individuals did not differ in their
NDV antibody concentration among treat-
ments at the beginning of the experiment
(F3,12051.76; P50.16). However, as indi-
cated by the significant interaction between
treatment and session (F9,12052.91; P5
0.004) differences among treatments ap-
peared after 1 wk (F3,12054.13; P50.008),
reached a maximum at week 4 (F3,1205
16.27; P,0.001), and remained unchanged
until week 6 (F3,12058.21; P,0.001; see
Fig. 1 for post hoc tests).
Leukocyte profile changed throughout
the experiment as the proportion of
lymphocytes (F2,10354.84; P50.010) and
monocytes (F2,10357.03; P50.001) de-
clined over time, but the proportion of
granulocytes increased (F2,10356.53;
P50.002), independently of treatment
FIGURE 1. House Sparrow (Passer domesticus )
response to experimental challenge with different
doses of inactivated Newcastle disease virus (NDV)
vaccine. Least-squares mean NDV antibody titers
among experimental treatments on vaccination day
(pretreatment), and 1, 4, and 6 wk postchallenge.
Values having the same letter within a given
experimental session are not significantly different
(P.0.05). Continuous lines within treatments indi-
cate a significant change between sampling sessions
(P,0.05). The horizontal dotted line indicates the
titer (16) above which samples were considered
positive.
TABLE 1. House Sparrow (Passer domesticus )
response to an experimental challenge with different
doses of inactivated Newcastle disease virus (NDV)
vaccine. Leukocyte profiles as measured by flow
cytometry: percentage (6SE) of lymphocytes (Lym),
granulocytes (Gra), and monocytes (Mon) among
treatments with their corresponding standard error, at
the beginning of the experiment, after week 1 and
week 6 postchallenge.
Treatment Pretreatment Week 1 Week 6
Control
Lym 0.2660.03 0.2160.03 0.1660.03
Gra 0.7060.03 0.7460.03 0.8160.03
Mon 0.0460.01 0.0560.01 0.0260.01
0.05 mL
Lym 0.2660.03 0.2160.03 0.2060.03
Gra 0.7060.04 0.7660.04 0.7860.04
Mon 0.0460.01 0.0460.01 0.0260.01
0.1 mL
Lym 0.2760.04 0.2460.03 0.2460.03
Gra 0.6760.04 0.7360.04 0.7360.04
Mon 0.0560.01 0.0560.01 0.0360.01
0.2 mL
Lym 0.2760.03 0.2660.03 0.1860.03
Gra 0.7060.04 0.6960.03 0.7960.03
Mon 0.0360.01 0.0460.01 0.0460.01
(all P.0.5, see Table 1). Leukocyte pro-
files were not related to antibody concen-
tration, either when included singly or
together as covariates in the previously
described models (all P.0.5).
As found in earlier studies on poultry,
the inactivated NDV vaccine elicited
a significant humoral response in wild
sparrows, but did not affect cell-mediated
immunity as measured by leukocyte pro-
files (Popovic et al., 2010). Different
treatments did not affect the birds’ serol-
ogy when sampled at week 1 postchal-
lenge, but a serologic response was
detected and peaked after week 4, re-
maining at this level until the end of the
experiment. The highest vaccine dose
(0.2 mL) induced a positive response in
week 1 after treatment, with titers over 1/
16; this response remained significantly
different from controls from week 4 until
week 6, as found by Lloyd and Wernery
(2008) in hybrid falcons. Both lower doses
of vaccine (0.05 and 0.1 mL) followed the
same pattern as described for the highest
dose, but the effects were not detectable
at week 1 after vaccination and titers
remained close to 1/16, which is normally
considered as the positive threshold for
the diagnosis of exposure to NDV (Alex-
ander, 2009).
We detected no cell-mediated response
to experimental vaccination. This agrees
with studies questioning the relevance of
cell-mediated immunity in the adaptive
response to NDV (Reynolds and Maraqa,
2000). All leukocyte profiles (lymphocytes,
granulocytes, and monocytes) remained
unaltered among treatments. However,
leukocyte profiles from all birds changed
as the experiment proceeded, most likely
as a result of a response to captivity. The
ratio of heterophils (i.e., granulocytes) to
lymphocytes is related to physiologic
stress (Mu¨ ller et al., 2011; Johnstone
et al., 2012). Inactivated NDV vaccine
elicits a humoral response in wild House
Sparrows with doses above 0.05 mL per
individual, and this response was traced
from week 4 to week 6 postchallenge. Our
results confirm the validity of these in vivo
immunologic methods, which can be used
in evolutionary, veterinary, and ecoepide-
miologic studies on wild fauna.
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